The 2025 Oncology Landscape
Our Oncology Landscape Review Series provides a data-driven analysis of the Oncology drug, trial, regulatory, commercial and patent landscape. Put yourself at the forefront of innovation with unparalleled insights into the dynamic and fast-paced world of Oncology drug development with Beacon Oncology.
Report Contents
The Drug Landscape
The Oncology pipeline increased by 15.6% in 2025, to 28,800 assets. Explore the therapeutic modalities driving this growth, and the top targets where development is most competitive.
The Trial Landscape
Clinical trial initiations grew by 11.8% in 2025. Discover the most popular biomarkers being investigated, and where activity is concentrated across the development spectrum.
The Commercial Landscape
A deep dive into 2025 deal activity across Oncology drug modalities, top targets, and disease indications, as well as an analysis of founded companies, early stage investments, and IPOs & M&As.
Regulatory Announcements
Review the regulatory momentum of 2025, including a breakdown of IND approvals by disease indication, the top drugs by regulatory activity and a timeline of novel FDA approvals.
The Oncology Patent Landscape
Examine the 2025 Q4 Oncology Patent Landscape, including patent application analysis by therapeutic class, the top current assignees, and publication country.
Future of the Oncology Landscape
An overview of the upcoming clinical trial landscape, and the Oncology assets to watch in 2026, including the top non-approved drugs with the highest clinical trial activity.
You May Also Be Interested In…
Learn More About Oncology
- The Most Comprehensive Way to Search the Oncology Drug Development Landscape: Unique search ontologies based on Oncology drug and trial characteristics
- Market Leading Approach to Oncology Preclinical & Clinical Data Curation: Manual curation of key Oncology research and development data points by Oncology research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Oncology company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
